Study suggests those who had COVID-19 may only need one vaccine dose
People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The findings, published in
Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient antibody response. The team found that those who did not have COVID-19 called COVID naïve did not have a full immune response until after receiving their second vaccine dose, reinforcing the importance of completing the two recommended doses for achieving strong levels of immunity.
Targeted News Service targetednews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from targetednews.com Daily Mail and Mail on Sunday newspapers.
Date Time
Penn Study Suggests Those Who Had COVID-19 May Only Need One Vaccine Dose
PHILADELPHIA People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The findings, published today in Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient antibody response. The team found that those who did not have COVID-19 called COVID naïve did not have a full immune response until after receiving their second vaccine dose, reinforcing the importance of completing the two recommended doses for achieving strong levels of immunity.
Covid survivors may only need one vaccine dose: Study
By IANS |
4 Views
Covid survivors may only need one vaccine dose: Study. Image Source: IANS News
Washington, April 16 : People who have recovered from Covid-19 require only one vaccine dose. A second jab is important for those who have not had Covid-19 to reach strong immunity, suggests a study.
The study, led by researchers from the University of Pennsylvania in the US, found that Covid survivors had a robust antibody response after the first mRNA vaccine dose, but little immune benefit was seen after the second dose.
On the other hand, those who did not have Covid-19 called Covid naive did not have a full immune response until after receiving their second vaccine dose, reinforcing the importance of completing the two recommended doses for achieving strong levels of immunity.
Researchers of the University of Pennsylvania in the US, say that people who have already been infected with COVID-19 show a great immune response after the first dose of the vaccine while there are only little benefits of the second dose.